NCEL NewcelX Ltd. Insider Trading

Director Samuel Olivier purchases over 81,000 shares of NewcelX at $2.75, signaling conviction amid sharp recovery.

Director Samuel Olivier committed approximately $225,000 to acquire over 81,000 shares of NewcelX at $2.75 per share, demonstrating meaningful personal conviction at a price substantially below the company's recent highs. The stock had fallen sharply from its peak but has rallied sharply in recent weeks, suggesting Olivier is buying into an inflection point rather than catching a falling knife—his purchase coincides with early-stage recovery momentum. The company operates at a modest market capitalization with fundamentals that warrant close examination; the director's sizable position increase suggests he sees undervalued opportunity in the current landscape. This is a classic insider accumulation signal during a recovery phase, though the small company size and modest absolute capital base mean follow-up research into operational trends, cash position, and competitive positioning is essential to validate Olivier's conviction.

CSO and Director Revel Michel purchases ~55k shares of NCEL at $2.75 in concentrated buying signal.

Revel Michel, Chief Strategy Officer and board director with substantial beneficial ownership, deployed roughly $150k to acquire over 54,000 shares at a depressed valuation. The stock is trading more than halfway below its recent highs, suggesting Michel is buying into weakness—a classic insider conviction signal when C-suite actors have direct operational knowledge. The purchase represents a meaningful 6% addition to his holdings, indicating confidence that current levels represent value rather than a continuing decline. Combined with the company's modest market cap and the stock's recovery trajectory over the prior month, this trade suggests internal visibility into stabilization or strategic progress that hasn't yet fully priced in. The timing and size of Michel's commitment warrant close monitoring for follow-through execution or upcoming catalysts.